The diagnosis was confirmed by endomyocardial biopsy-consistent with hypertrophic cardiomyopathy-and genetic testing, which identified a pathogenic MYH7 variant (c.4145G>A, p.R1382Q). This evidence concerns the gene MYH7 and hypertrophic cardiomyopathy.